The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach

Autor: Tom van Gils, Talha G. Senler, Henriëtte E. van der Horst, Chris J.J. Mulder, Gerd Bouma, Henk de Vries

Publikováno v: European Journal of General Practice, Vol 24, Iss 1, Pp 236-242 (2018)

Background: General practitioners (GPs) play a crucial role in diagnosing coeliac disease (CD). However, data on GP management of (suspected) CD patients is sparse. Objectives: To provide insights into the daily practice of diagnosis, treatment, and

Externí odkaz: https://doaj.org/article/2b1f675448a542a28fff038fcb80ab62

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

Autor: Ciaran P. Kelly, Garbiñe Roy Ariño, Anthony J. DiMarino, George Vlad, Laura Crespo, Raquel Perez Maseda, Amélie Trinquand, Ralph Raymond, Michael Schumann, Anne Blanchard, Olivier Hermine, Georgia Malamut, Jane R. Parnes, Samuli Rounioja, Eric Butz, Valerie Byrnes, Hetty J. Bontkes, Wayne Tsuji, Christophe Cellier, Gerd Bouma, Beth Llewellyn, Nadine Cerf-Bensussan, Tom van Gils, Peter H.R. Green, Joseph A. Murray, Govind Bhagat, Jack D. Bui, Ashleigh Palmer, Bana Jabri, Knut E.A. Lundin, Elizabeth Macintyre, Pekka Collin, Carlota García-Hoz, Sherine Khater, Bertrand Meresse, Francisco Leon, Chris J. J. Mulder, Sheila E. Crowe, David S Sanders, Michel Azizi, Marios Hadjivassiliou, Keijo Viiri

Publikováno v: Cellier, C, Bouma, G, van Gils, T, Khater, S, Malamut, G, Crespo, L, Collin, P, Green, P H R, Crowe, S E, Tsuji, W, Butz, E, Cerf-Bensussan, N, Macintyre, E, Parnes, J R, Leon, F, Hermine, O, Mulder, C J, Jabri, B, Murray, J, DiMarino, A, Kelly, C P, Byrnes, V, Sanders, D, Lundin, K E A, Schumann, M, Bontkes, H, Meresse, B, Roy Ariño, G, Bhagat, G, Viiri, K, Rounioja, S, Bui, J, Perez Maseda, R, García-Hoz, C, Trinquand, A, Vlad, G, Hadjivassiliou, M, Azizi, M, Blanchard, A, Llewellyn, B, Palmer, A & Raymond, R 2019, ' Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study ', The Lancet Gastroenterology and Hepatology, vol. 4, no. 12, pp. 960-970 . https://doi.org/10.1016/S2468-1253(19)30265-1
The Lancet Gastroenterology and Hepatology
The Lancet Gastroenterology and Hepatology, Elsevier, 2019, 4, pp.960-970. ⟨10.1016/S2468-1253(19)30265-1⟩
The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology, 2019, 4, pp.960-970. ⟨10.1016/S2468-1253(19)30265-1⟩
The Lancet Gastroenterology and Hepatology, 4(12), 960-970. Elsevier Ltd

Summary Background Refractory coeliac disease type 2 is a rare subtype of coeliac disease with high mortality rates; interleukin 15 (IL-15) is strongly implicated in its pathophysiology. This trial aimed to investigate the effects of AMG 714, an anti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f631e02be7147c01be92c9a499e939b5
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074226957&origin=inward

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult‐onset celiac disease: Consequences for follow‐up

Autor: Michael Hauptmann, Daan Ar Castelijn, Gerd Bouma, Flora E. van Leeuwen, Chris Jj Mulder, Lucy I. H. Overbeek, Daphne de Jong, Petula Nijeboer, Tom van Gils

Publikováno v: United European Gastroenterology Journal
United European Gastroenterology Journal, 6(10), 1485-1495. SAGE Publications Inc.
van Gils, T, Nijeboer, P, Overbeek, L I, Hauptmann, M, Castelijn, D A, Bouma, G, Mulder, C J, van Leeuwen, F E & de Jong, D 2018, ' Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease : Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma ', United European Gastroenterology Journal, vol. 6, no. 10, pp. 1485-1495 . https://doi.org/10.1177/2050640618800540

Background: The association between celiac disease (CD) and the development of lymphoid and gastrointestinal (GI) malignancies have been reported. However, data are scarce yet needed to develop evidence-based follow-up programs.Objective: The objecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cdc284a6ad6e344abaedc2c02309e4b
https://doi.org/10.1177/2050640618800540

Self-reported oral health and xerostomia in adult patients with celiac disease versus a comparison group

Autor: Hetty J. Bontkes, Tom van Gils, Chris J. J. Mulder, Henk S. Brand, Gerd Bouma

Publikováno v: van Gils, T, Bouma, G, Bontkes, HJ, Mulder, CJJ & Brand, H S 2017, ' Self-reported oral health and xerostomia in adult patients with celiac disease versus a comparison group ', Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 124, no. 2, pp. 152-156 . https://doi.org/10.1016/j.oooo.2017.05.475
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 124(2), 152-156. Elsevier
van Gils, T, Bouma, G, Bontkes, H J, Mulder, C J J & Brand, H S 2017, ' Self-reported oral health and xerostomia in adult patients with celiac disease versus a comparison group ', Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 124, no. 2, pp. 152-156 . https://doi.org/10.1016/j.oooo.2017.05.475
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 124(2), 152-156. Elsevier USA

Objectives. This study aimed to assess the impact of celiac disease (CD) on oral health and xerostomia. Study Design. Members of the Dutch Celiac Society (n = 5522) were invited to complete an online questionnaire based on the Oral Health Impact Prof

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f2260597a1ee2ed9a538c79aa98a5b
https://dare.uva.nl/personal/pure/en/publications/selfreported-oral-health-and-xerostomia-in-adult-patients-with-celiac-disease-versus-a-comparison-group(f6fcc60b-63e0-4a95-a455-5f8ac2099120).html

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: A CELAC study

Autor: Nicolas Guegan, Florence Lhospice, Sascha Cording, Amélie Trinquand, Julie Bruneau, Olivier Hermine, Virginie Verkarre, Nicole Brousse, Christophe Cellier, Georgia Malamut, Elizabeth Macintyre, Felipe Suarez, Laurent Frenzel, Vahid Asnafi, Morgane Cheminant, Sherine Khater, Bertrand Meresse, Ambroise Marçais, Nadine Cerf-Bensussan, Tom van Gils, Chris J. J. Mulder, Thierry Jo Molina, Ludovic Lhermitte, C. cile Bonnafous, David Sibon, Anne-Sophie Jannot, Richard Delarue, Laurent Pouyet

Publikováno v: Gut, 68(8), 1396-1405. BMJ Publishing Group
Gut
Gut, BMJ Publishing Group, 2019, 68 (8), pp.1396-1405. ⟨10.1136/gutjnl-2018-317371⟩
Cheminant, M, Bruneau, J, Malamut, G, Sibon, D, Guegan, N, van Gils, T, Cording, S, Trinquand, A, Verkarre, V, Lhermitte, L, Brousse, N, Jannot, A-S, Khater, S, Frenzel, L, Delarue, R, Suarez, F, Marçais, A, Mulder, C J J, Macintyre, E, Asnafi, V, Pouyet, L, Bonnafous, C C, Lhospice, F, Molina, T J, Meresse, B, Cellier, C, Cerf-Bensussan, N & Hermine, O 2019, ' NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: A CELAC study ', Gut, vol. 68, no. 8, pp. 1396-1405 . https://doi.org/10.1136/gutjnl-2018-317371
Gut, 2019, 68 (8), pp.1396-1405. ⟨10.1136/gutjnl-2018-317371⟩

ObjectivesPrimary GI T-cell lymphoproliferative diseases (T-LPD) are heterogeneous entities, which raise difficult diagnosis and therapeutic challenges. We have recently provided evidences that lymphomas complicating coeliac disease (CD) arise from i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bf16bc8e37754465b0cd121bf54c22
https://research.vumc.nl/en/publications/c070e3fd-4cc5-486e-8710-e1f8ba369480